Track Speciality Medicines Ltd.'s current share price, historical price chart, 52-week high/low, and performance across different time periods.
1 Week returns: -15.27 %
Low
140.0
High
170.0
1 Month returns: -2.37 %
Low
140.0
High
210.0
1 Year returns: –
3 Year CAGR: –
5 Year CAGR: –
Note: Prices may be delayed by a few minutes. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
Multi-year trends for Speciality Medicines Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.
Speciality Medicines Ltd. Shareholding Pattern
Quarterly breakdown of Speciality Medicines Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.
Bulk, Block and Insider Trades
Recent bulk deals, block deals, and insider trading activity in Speciality Medicines Ltd. shares as reported to NSE and BSE.
Frequently Asked Questions
What is the current share price of Speciality Medicines Ltd.?
The current share price of Speciality Medicines Ltd. is ₹ 144.00 as of 23 Oct 2026.
What is the market capitalisation of Speciality Medicines Ltd.?
The market capitalisation of Speciality Medicines Ltd. stands at ₹ 130.91 Cr.
What is the PE ratio of Speciality Medicines Ltd.?
The Price-to-Earnings (PE) ratio of Speciality Medicines Ltd. is 10.04 as of the latest trailing twelve months data.
What is the ROE and ROCE of Speciality Medicines Ltd.?
Speciality Medicines Ltd. has a Return on Equity (ROE) of 25.60% and a Return on Capital Employed (ROCE) of 23.80% as per the latest financial reports.
What is the 52-week high and low of Speciality Medicines Ltd.?
The 52-week high of Speciality Medicines Ltd. is - and the 52-week low is -.
What is the dividend yield of Speciality Medicines Ltd.?
The dividend yield of Speciality Medicines Ltd. is 0.00% based on the current market price.
What is the FII and DII holding in Speciality Medicines Ltd.?
Foreign Institutional Investors (FII) hold -, Domestic Institutional Investors (DII) hold - of Speciality Medicines Ltd. shares.
What sector does Speciality Medicines Ltd. belong to?
Speciality Medicines Ltd. operates in the Healthcare sector.
What is the beta of Speciality Medicines Ltd.?
The beta of Speciality Medicines Ltd. is -, indicating its price volatility relative to the broader market.
What is the RSI of Speciality Medicines Ltd.?
The 14-day Relative Strength Index (RSI) of Speciality Medicines Ltd. is 41.96, placing it in the neutral zone. An RSI above 70 is considered overbought and below 30 is considered oversold.
Stock Analysis
Fundamental analysis overview of Speciality Medicines Ltd. covering key investment insights, growth drivers, risk factors, and potential red flags.
Views
Red Flags
Positive
Stock is cheap and PE TTM is at a discount to industry median
PE TTM of 10.04 indicates that the stock is cheap on a standalone basis. Discount to industry median P/E is decent at -67.39%
What is P/E Ratio?
Median: 30.79
Value 10.04
-0.85654.83
Company is net cash
The company is net cash i.e., cash and cash equivalents exceed total debt indicating a healthy balance sheet
What is Net Debt ?
Negative
Weak price momentum
Price Momentum score of 18.3 indicates that the stock has weak price momentum. Research has shown that stocks with lower momentum continue to underperform in the near term
What is Price Momentum score?
18.3 / 100
Company's earnings are of low quality
Earnings quality score of 22.5 indicates that the company's earnings are of low quality. Earnings quality is measured using combination of earnings persistence, probability of manipulation and earnings to cash conversion
What is Earnings quality score?
22.5 / 100
Low dividend yield
The company has a low dividend yield of 0.0%
What is Dividend yield?
Neutral
Not enough talking points with neutral stance
Thinly traded (low daily turnover)
The stock is thinly traded with combined (NSE & BSE) daily turnover (21-day average) of 0.20621.
Dec 2025
Mar 2026
Total Promoter
-
43.43
Indian Promoter
-
43.43
Foreign Promoter
-
-
Institutions
-
0.24
Mutual Funds / UTI
-
-
FI/Bank/Insurance
0.00
0.00
Govt
-
-
FII
0.00
0.24
Other Institutions
0.00
0.00
Non-Institution
-
56.33
Bodies Corporate
-
1.06
Others (incl. Retail)
No. of shareholders
0.00
0
55.27
741
Company Profile
Overview of Speciality Medicines Ltd. covering business description, industry classification, key management, financial ratios, and listed exchange details.
Speciality Medicines Limited is an India-based pharmaceutical company. The Company is engaged in marketing and distribution of finished formulations of specialty pharmaceuticals. It offers a diverse portfolio of specialty pharmaceuticals, focusing on therapeutic areas such as oncology, immunology, neurology, and rare diseases. It deals in finished formulations of specialty pharmaceuticals, including capsules, cream, eye drops, gel, infusion, inhalation, inhaler, injection, nasal spray, ointment, ophthalmic, oral solution, oral suspension, sachet, suspension and tablet. Its product portfolio consists of more than 900 products, which comprises of wide range of therapeutic drugs such as ACE inhibitors, Analgesic, Antiulcer, Anti angiogenic, Anti-acne, and Anti fibrinolytic, among others. Under the sale of specialty pharmaceutical finished formulation in the domestic market, it sources existing Indian medicine brands from manufacturers and their authorized distributors.
Speciality Medicines Limited is an India-based pharmaceutical company. The Company is engaged in marketing and distribution of finished formulations of specialty pharmaceuticals. It offers a diverse portfolio of specialty pharmaceuticals, focusing on therapeutic areas such as oncology, immunology, n...
Key personnel
Mr. Kalpesh Bharatbhai Pipaliya
Chief Financial Officer
Ms. Anita Kumawat
Compliance Officer, Company Secretary
Ms. Vandana Siyasharan Vashwakarma
Purchase Executive
Mr. Parthkumar Babulal GoyaniD
Executive Chairman of the Board, Managing Director